[go: up one dir, main page]

MC1396A1 - Interferons et procede pour leur preparation - Google Patents

Interferons et procede pour leur preparation

Info

Publication number
MC1396A1
MC1396A1 MC811525A MC1525A MC1396A1 MC 1396 A1 MC1396 A1 MC 1396A1 MC 811525 A MC811525 A MC 811525A MC 1525 A MC1525 A MC 1525A MC 1396 A1 MC1396 A1 MC 1396A1
Authority
MC
Monaco
Prior art keywords
leif
human leukocyte
interferon
leukocyte interferon
amino acid
Prior art date
Application number
MC811525A
Other languages
English (en)
French (fr)
Inventor
Norman D Goeddel
Sidney Pestka
Original Assignee
Hoffmann La Roche
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27496622&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MC1396(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US06/256,204 external-priority patent/US6610830B1/en
Application filed by Hoffmann La Roche, Genentech Inc filed Critical Hoffmann La Roche
Publication of MC1396A1 publication Critical patent/MC1396A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/71—Expression systems using regulatory sequences derived from the trp-operon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
MC811525A 1980-07-01 1981-06-29 Interferons et procede pour leur preparation MC1396A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US16498680A 1980-07-01 1980-07-01
US18490980A 1980-09-08 1980-09-08
US20557880A 1980-11-10 1980-11-10
US06/256,204 US6610830B1 (en) 1980-07-01 1981-04-21 Microbial production of mature human leukocyte interferons

Publications (1)

Publication Number Publication Date
MC1396A1 true MC1396A1 (fr) 1982-04-27

Family

ID=27496622

Family Applications (1)

Application Number Title Priority Date Filing Date
MC811525A MC1396A1 (fr) 1980-07-01 1981-06-29 Interferons et procede pour leur preparation

Country Status (36)

Country Link
EP (2) EP0043980B1 (fi)
AR (1) AR242833A1 (fi)
AT (3) ATE29727T1 (fi)
AU (1) AU552004B2 (fi)
BG (1) BG42189A3 (fi)
BR (1) BR8104189A (fi)
CH (2) CH657141A5 (fi)
CS (1) CS273152B2 (fi)
DD (3) DD210304A5 (fi)
DE (3) DE3177288T3 (fi)
DK (1) DK173543B1 (fi)
DZ (1) DZ312A1 (fi)
ES (1) ES503528A0 (fi)
FI (1) FI82712C (fi)
FR (1) FR2486098B1 (fi)
GB (1) GB2079291B (fi)
GE (1) GEP19960519B (fi)
GR (1) GR75714B (fi)
HK (1) HK49285A (fi)
HU (1) HU196457B (fi)
IE (1) IE49255B1 (fi)
IT (1) IT1137272B (fi)
KE (1) KE3534A (fi)
LU (1) LU83461A1 (fi)
MC (1) MC1396A1 (fi)
MY (1) MY8700711A (fi)
NL (1) NL8103151A (fi)
NO (1) NO159392C (fi)
NZ (1) NZ197572A (fi)
PH (1) PH18036A (fi)
PL (3) PL148261B1 (fi)
PT (1) PT73289B (fi)
RO (1) RO87590A (fi)
SE (2) SE8104093L (fi)
SU (1) SU1414319A3 (fi)
YU (1) YU47700B (fi)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA811368B (en) * 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
CA1341604C (en) 1980-04-03 2010-05-04 Biogen N.V. Dna sequences, recombinant dna molecules and processes for producing human fibroblast interferon-like polypeptides
DE3176011D1 (en) * 1980-06-12 1987-04-23 Japan Found Cancer Plasmid
DK489481A (da) * 1980-11-10 1982-05-11 Searle & Co Plasmidvektor og frmgangsmaade til fremstilling deraf
NZ199722A (en) * 1981-02-25 1985-12-13 Genentech Inc Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain
JPS58501543A (ja) * 1981-08-14 1983-09-16 エイ／エス　アルフレツド　ベンツオン ヒトインタ−フエロン蛋白とヒトインタ−フエロン蛋白に対する抗体に関する改良
JPS58110548A (ja) * 1981-12-24 1983-07-01 Asahi Chem Ind Co Ltd 新規な生理活性ペプチド
US5098703A (en) * 1982-01-15 1992-03-24 Cetus Corporation Interferon-alpha 76
US4975276A (en) * 1982-01-15 1990-12-04 Cetus Corporation Interferon-alpha 54
US4973479A (en) * 1982-01-15 1990-11-27 Cetus Corporation Interferon-α61
US4775622A (en) * 1982-03-08 1988-10-04 Genentech, Inc. Expression, processing and secretion of heterologous protein by yeast
US5827694A (en) * 1982-03-08 1998-10-27 Genentech, Inc. DNA encoding non-human animal interferons, vectors and hosts therefor, and recombinant production of IFN polypeptides
IE54592B1 (en) * 1982-03-08 1989-12-06 Genentech Inc Anumal interferons, processes involved in their production, compositions containing them, dna sequences coding therefor and espression vehicles containing such sequences and cells transformed thereby
US6432677B1 (en) 1982-03-08 2002-08-13 Genentech, Inc. Non-human animal interferons
EP0088994B1 (en) * 1982-03-15 1991-06-19 Schering Corporation Hybrid dna, binding composition prepared thereby and processes therefor
US4695543A (en) * 1982-03-23 1987-09-22 Bristol-Myers Company Alpha Interferon GX-1
CA1210714A (en) * 1982-03-23 1986-09-02 Alan Sloma .alpha.-INTERFERON GX-1
US4748233A (en) * 1982-03-23 1988-05-31 Bristol-Myers Company Alpha-interferon Gx-1
US6936694B1 (en) * 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
US5831023A (en) * 1982-11-01 1998-11-03 Genentech, Inc. Recombinant animal interferon polypeptides
WO1984003300A1 (fr) * 1983-02-24 1984-08-30 Inst Organicheskogo Sinteza Ak Interferon n humain leucocytaire et son procede d'obtention dans des cellules bacteriennes
WO1985002862A1 (en) * 1983-12-23 1985-07-04 Monash University PRODUCTION OF HUMAN INTERFERON-alpha
SU1364343A1 (ru) * 1984-07-13 1988-01-07 Всесоюзный научно-исследовательский институт генетики и селекции промышленных микроорганизмов Способ получени человеческого лейкоцитарного интерферона альфа-2
IL76360A0 (en) 1984-09-26 1986-01-31 Takeda Chemical Industries Ltd Mutual separation of proteins
WO1986002068A1 (fr) * 1984-09-26 1986-04-10 Takeda Chemical Industries, Ltd. Separation mutuelle de proteines
DE3515336C2 (de) * 1985-04-27 1994-01-20 Boehringer Ingelheim Int Verfahren zur Herstellung und Reinigung von â-Interferon
US5196323A (en) * 1985-04-27 1993-03-23 Boehringer Ingelheim International Gmbh Process for preparing and purifying alpha-interferon
JP2514950B2 (ja) * 1986-03-10 1996-07-10 エフ・ホフマン―ラ ロシユ アーゲー 化学修飾蛋白質，その製造法および中間体
JPS6463395A (en) * 1987-05-04 1989-03-09 Oncogen Oncostatin m and novel composition having antitumor activity
CA1309044C (en) * 1987-11-09 1992-10-20 Toshiya Takano Method of producing foreign gene products
GB8813032D0 (en) * 1988-06-02 1988-07-06 Boehringer Ingelheim Int Antiviral pharmaceutical composition
WO1991003251A1 (en) * 1989-09-08 1991-03-21 California Institute Of Biological Research Cr2 ligand compositions and methods for modulating immune cell functions
DE3932311A1 (de) * 1989-09-28 1991-04-11 Boehringer Ingelheim Int Verfahren zur reinigung von beta-interferon
PT741577E (pt) * 1994-03-07 2003-03-31 Imperial College Utilizacao do subtipo de interferao alfa 8 na preparacao de medicamentos para tratar infeccoes virais do figado
ES2161793T3 (es) * 1994-04-09 2001-12-16 Hoffmann La Roche Proceso para la produccion de alfa-interferona.
GB9609932D0 (en) * 1996-05-13 1996-07-17 Hoffmann La Roche Use of IL-12 and IFN alpha for the treatment of infectious diseases
US20030190307A1 (en) 1996-12-24 2003-10-09 Biogen, Inc. Stable liquid interferon formulations
ZA9811070B (en) 1997-12-08 2000-07-03 Genentech Inc Type I interferons.
JP2001526033A (ja) 1997-12-08 2001-12-18 ジェネンテク・インコーポレイテッド ヒトインターフェロン−イプシロンというｉ型インターフェロン
CA2728907C (en) 1998-08-06 2015-11-24 Mountain View Pharmaceuticals, Inc. Peg-urate oxidase conjugates and use thereof
US6783965B1 (en) 2000-02-10 2004-08-31 Mountain View Pharmaceuticals, Inc. Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates
US6268178B1 (en) 1999-05-25 2001-07-31 Phage Biotechnology Corp. Phage-dependent super-production of biologically active protein and peptides
EP2292652A2 (en) * 2000-11-03 2011-03-09 Pestka Biomedical Laboratories, Inc. Interferons uses and compositions related thereto
FR2822845B1 (fr) 2001-03-30 2003-12-12 Genodyssee Nouveaux polynucleotides comportant des polymorphismes de type snp fonctionnels dans la sequence nucleotidique du gene ifn-alpha-21 ainsi que de nouveaux polypeptides codes par ces polynucleotides et leurs utilisations therapeutiques
FR2823220B1 (fr) 2001-04-04 2003-12-12 Genodyssee Nouveaux polynucleotides et polypeptides de l'erythropoietine (epo)
FR2825716B1 (fr) 2001-06-11 2004-09-24 Genodyssee Nouveaux polynucleotides et polypeptides de l'ifn alpha 7
PT3321359T (pt) 2005-04-11 2021-03-11 Horizon Pharma Rheumatology Llc Formas variantes de urato-oxidase e a sua utilização
US20110034672A1 (en) * 2008-01-18 2011-02-10 Roberto Falkenstein Purification of not-glycosylated polypeptides
EP2446260B1 (en) 2009-06-25 2018-12-26 Horizon Pharma Rheumatology LLC Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy
JP2019535819A (ja) 2016-11-11 2019-12-12 ホライゾン ファーマ リューマトロジー リミテッド ライアビリティ カンパニーＨｏｒｉｚｏｎ Ｐｈａｒｍａ Ｒｈｅｕｍａｔｏｌｏｇｙ Ｌｌｃ プレドニゾンおよびウリカーゼ分子の併用療法ならびにその使用
WO2018087345A1 (en) 2016-11-14 2018-05-17 F. Hoffmann-La Roche Ag COMBINATION THERAPY OF AN HBsAg INHIBITOR, A NUCLEOS(T)IDE ANALOGUE AND AN INTERFERON
WO2020160325A1 (en) 2019-01-30 2020-08-06 Horizon Pharma Rheumatology Llc Reducing immunogenicity to pegloticase
US12269875B2 (en) 2023-08-03 2025-04-08 Jeff R. Peterson Gout flare prevention methods using IL-1BETA blockers

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN150740B (fi) * 1978-11-24 1982-12-04 Hoffmann La Roche
FI77877C (fi) * 1979-04-20 1989-05-10 Technobiotic Ltd Foerfarande foer framstaellning och rening av human le-formig interferonprotein.
AU553400B2 (en) * 1980-01-08 1986-07-17 Biogen, Inc. Recombinant dna for producing interferon
DE3005897A1 (de) * 1980-02-16 1981-09-03 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enhtaltenden mikroorganismus
DE3176011D1 (en) * 1980-06-12 1987-04-23 Japan Found Cancer Plasmid
ES8302778A1 (es) * 1980-11-10 1983-02-01 Genentech Inc Un procedimiento para producir un polipeptido antiviral.
FI64813C (fi) * 1980-12-31 1984-01-10 Ilkka Antero Palva Foerfarande foer producering av ett utvalt aeggviteaemne och vid foerfarandet anvaenda rekombinantplasmidvektorer
EP0062971B1 (en) * 1981-03-27 1990-03-07 Imperial Chemical Industries Plc Genetically modified microorganisms

Also Published As

Publication number Publication date
NO159392C (no) 1988-12-21
AU552004B2 (en) 1986-05-22
CS503781A2 (en) 1990-07-12
HK49285A (en) 1985-07-05
AR242833A1 (es) 1993-05-31
ES8207514A1 (es) 1982-10-01
EP0043980A3 (en) 1982-09-15
PH18036A (en) 1985-03-06
DE3125706C2 (de) 1995-05-24
RO87590A (ro) 1986-07-30
NO159392B (no) 1988-09-12
HU196457B (en) 1988-11-28
DD202307A5 (de) 1983-09-07
GR75714B (fi) 1984-08-02
EP0043980A2 (en) 1982-01-20
MY8700711A (en) 1987-12-31
KE3534A (en) 1985-06-07
PL148260B1 (en) 1989-09-30
NZ197572A (en) 1985-07-31
EP0211148B1 (en) 1992-08-26
DE3177288T2 (de) 1992-12-10
LU83461A1 (de) 1983-04-06
EP0211148B2 (en) 1999-11-24
CH657141A5 (de) 1986-08-15
ATE79901T1 (de) 1992-09-15
DD210305A5 (de) 1984-06-06
BG42189A3 (en) 1987-10-15
DE3125706A1 (de) 1982-04-15
PL148276B1 (en) 1989-09-30
NL8103151A (nl) 1982-02-01
ATA290981A (de) 1985-09-15
ATE29727T1 (de) 1987-10-15
IE49255B1 (en) 1985-09-04
GB2079291A (en) 1982-01-20
GEP19960519B (en) 1996-07-02
SE465223C5 (sv) 1998-02-10
FI82712C (fi) 1991-04-10
PL231940A1 (en) 1983-07-18
SE465223B (sv) 1991-08-12
ES503528A0 (es) 1982-10-01
EP0211148A1 (en) 1987-02-25
YU162281A (en) 1984-02-29
YU47700B (sh) 1996-01-08
PL148261B1 (en) 1989-09-30
DE3177288D1 (de) 1992-10-01
NO812247L (no) 1982-01-04
SE8104093L (sv) 1982-01-02
IE811463L (en) 1982-01-01
CS273152B2 (en) 1991-03-12
SU1414319A3 (ru) 1988-07-30
FR2486098B1 (fr) 1985-12-27
DZ312A1 (fr) 2004-09-13
EP0043980B1 (en) 1987-09-16
PT73289A (en) 1981-07-01
DE3177288T3 (de) 2000-03-16
AU7246281A (en) 1982-01-07
FI82712B (fi) 1990-12-31
IT8122682A0 (it) 1981-07-01
DK291081A (da) 1982-01-02
BR8104189A (pt) 1982-03-16
IT1137272B (it) 1986-09-03
CH651308A5 (de) 1985-09-13
FR2486098A1 (fr) 1982-01-08
DD210304A5 (de) 1984-06-06
PT73289B (en) 1983-05-11
DK173543B1 (da) 2001-02-05
DE3176448D1 (en) 1987-10-22
FI812067L (fi) 1982-01-02
AT380272B (de) 1986-05-12
GB2079291B (en) 1984-06-13

Similar Documents

Publication Publication Date Title
MC1396A1 (fr) Interferons et procede pour leur preparation
MC1423A1 (fr) Production microbienne d'interferon de fibroplaste humain
MC1424A1 (fr) Interferons de leucocytes humains hybrides et procede pour leur preparation microbiologique
CA1341583C (en) Interferons and process for their preparation
CH672790A5 (fi)
BE898016A (fr) Muteines appauvries en cysteine provenant de proteines biologiquement actives.
CA2035900C (fr) Proteine a activite urate oxydase, gene recombinant codant pour celle-ci, vecteur d'expression, micro-organismes et cellules transformees
MC1553A1 (fr) Proteine d'interferon immunitaire humain et son procede de production
US4801685A (en) Microbial production of mature human leukocyte interferon K and L
JPS6363199B2 (fi)
US4810645A (en) Microbial production of mature human leukocyte interferon K and L
FR2481316A1 (fr) Technique a adn de recombinant pour la preparation d'une proteine ressemblant a l'interferon humain
FI82714B (fi) Foerfarande foer framstaellning av en transformerad stam av e.coli, som foermaor expressera ett humant moget leukocytinterferon.
KR870000510B1 (ko) 형질전환된 미생물의 제조방법
MC1500A1 (fr) Adn nouveau et son procede de production
KR910009901B1 (ko) 하이브리드 인간 백혈구 인터페론
BE887397A (fr) Technique a adn de recombinant pour la preparation d'une proteine ressemblant a l'interferon humain
IL63197A (en) Intraferons for mature human oocytes, their preparation and preparations containing them
SI8111622A (sl) Interferoni in postopek za njihovo pridobivanje
CS273181B2 (en) Method of escherichia coli cells production that are capable to produce mature human leucocytic interferon

Legal Events

Date Code Title Description
YP Annual fee paid